Clear science for curious people
ScienceBlog.com
Writer at Science Blog

ScienceBlog.com

Profile →

Health

Genetic variation associated with poorer response, cardiovascular outcomes with use of clopidogrel

Patients with a certain genetic variation who received the antiplatelet drug clopidogrel had a decreased platelet response to treatment and among those who had percutaneous coronary intervention (procedures such as balloon angioplasty or stent placement used to open narrowed coronary arteries) had an increased risk of having a cardiovascular event in the following year than patients who did not

Aug 25, 2009